Alpine Immune Sciences

Developer of immunotherapies to treat cancer and autoimmune disorders

placeSeattle, Washington, United States calendar_todayFounded 2015 groups126 employees language alpineimmunesciences.com

Registered entities

Investor mix

12 investors on record; lead investors include Alpine Bioventures; 4 have since exited.

Investor typeCountShare
Venture capital758%
Private equity325%
Bank & private debt18%
Other / undisclosed18%
Coming soon